Baird Maintains Outperform on Alignment Healthcare, Raises Price Target to $11
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Michael Ha maintains an Outperform rating on Alignment Healthcare (NASDAQ:ALHC) and raises the price target from $10 to $11.
August 14, 2024 | 11:39 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baird analyst Michael Ha maintains an Outperform rating on Alignment Healthcare and raises the price target from $10 to $11.
The Outperform rating and increased price target from a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100